Pulse Biosciences Updates on CellFX System Regulatory and Clinical Study Progress

Author's Avatar
Jan 12, 2021
Article's Main Image

Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced CellFX® System regulatory progress updates.